Jusvinza, an anti-inflammatory drug derived from the human heat-shock protein 60, for critically ill COVID-19 patients. An observational study

por Venegas-Rodríguez, Rafael, Serrano-Díaz, Anabel, Peña-Ruiz, Ruben, Santana-Sánchez, Raul, Hernández-Cedeño, Mabel, Rittoles Navarro, Aliusha, Grecesqui-Cruz, Inti, Pérez-Aguilera, Liam, Segura-Fernández, Anadys, Rosario-Cruz, Leticia, Martínez-Donato, Gilliam, Guillén-Nieto, Gerardo, Domínguez- Horta, Maria del Carmen
Publicado 2023